The effect of Water-Based rhythmic exercise training in postmenopausal women with Metabolic Syndrome

The effect of Water-Based rhythmic exercise training on Leptin, Aldosterone and Cardiovascular risk factors in postmenopausal women with Metabolic Syndrome

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200625047917N1

Enrollment

Registered

2020-06-28

Start date

2020-06-30

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome. Metabolic syndrome

Interventions

Intervention 1: Intervention group:12 weeks of Water-Based rhythmic exercise training ,three sessions per week, 60 minutes each session. Exercise training program consists of 10 minutes warming up, 45

Eligibility

Sex/Gender

Female

Age

65 Years to 75 Years

Inclusion criteria

Inclusion criteria: Having age ranges of 65-75 years Postmenopausa No regular exercise Suffering from at least three of the five indicators of metabolic syndrome: abdominal obesity (waist circumference more than 88 cm), triglycerides greater than 150 mg / dl, blood pressure more than 130.85 ml of mercury, fasting blood glucose more than 110 ml / dl And high-density lipoprotein (HDL) less than 50 mg / dl Lack of diabetes, liver, kidney, inflammation and respiratory diseases

Exclusion criteria

Exclusion criteria: More than three session absence from the training injury during training

Design outcomes

Primary

Measure	Time frame
Aldosterone. Timepoint: Before and after the end of interventions. Method of measurement: using ELISA Kit.;Leptin. Timepoint: Before and after the end of interventions. Method of measurement: using ELISA Kit.;High-sensitivity C-reactive Protein (hs-CRP). Timepoint: Before and after the end of interventions. Method of measurement: using ELISA Kit.;Fast blood sugar. Timepoint: Before and after the end of interventions. Method of measurement: using ELISA Kit.;Blood pressure. Timepoint: Before and after the end of interventions. Method of measurement: Using the blood pressure device.;Insulin hormone. Timepoint: Before and after the end of interventions. Method of measurement: Serum levels using Eliza method.;Albumin. Timepoint: Before and after the end of interventions. Method of measurement: Using Colorimetric.;Triglyceride. Timepoint: Before and after the end of interventions. Method of measurement: According to milligrams per deciliter and by Baseline blood.;Low-density lipoprotein. Timepoint: Before and after the end of interventions. Method of measurement: According to milligrams per deciliter and by Baseline blood.;High-density lipoprotein. Timepoint: Before and after the end of interventions. Method of measurement: According to milligrams per deciliter and by Baseline blood.;Cholstrol. Timepoint: Before and after the end of interventions. Method of measurement: According to milligrams per deciliter and by Baseline blood.;Waist circumference. Timepoint: Before and after the end of interventions. Method of measurement: According to cm and by Tape measure.;Body mass index. Timepoint: Before and after the end of interventions. Method of measurement: According to Kg/m2 and dividing body weight by the square of the height(m2).;Fat percent. Timepoint: Before and after the end of interventions. Method of measurement: Using InBody.	—

Measure

Time frame

Aldosterone. Timepoint: Before and after the end of interventions. Method of measurement: using ELISA Kit.;Leptin. Timepoint: Before and after the end of interventions. Method of measurement: using ELISA Kit.;High-sensitivity C-reactive Protein (hs-CRP). Timepoint: Before and after the end of interventions. Method of measurement: using ELISA Kit.;Fast blood sugar. Timepoint: Before and after the end of interventions. Method of measurement: using ELISA Kit.;Blood pressure. Timepoint: Before and after the end of interventions. Method of measurement: Using the blood pressure device.;Insulin hormone. Timepoint: Before and after the end of interventions. Method of measurement: Serum levels using Eliza method.;Albumin. Timepoint: Before and after the end of interventions. Method of measurement: Using Colorimetric.;Triglyceride. Timepoint: Before and after the end of interventions. Method of measurement: According to milligrams per deciliter and by Baseline blood.;Low-density lipoprotein. Timepoint: Before and after the end of interventions. Method of measurement: According to milligrams per deciliter and by Baseline blood.;High-density lipoprotein. Timepoint: Before and after the end of interventions. Method of measurement: According to milligrams per deciliter and by Baseline blood.;Cholstrol. Timepoint: Before and after the end of interventions. Method of measurement: According to milligrams per deciliter and by Baseline blood.;Waist circumference. Timepoint: Before and after the end of interventions. Method of measurement: According to cm and by Tape measure.;Body mass index. Timepoint: Before and after the end of interventions. Method of measurement: According to Kg/m2 and dividing body weight by the square of the height(m2).;Fat percent. Timepoint: Before and after the end of interventions. Method of measurement: Using InBody.

—

Secondary

Measure	Time frame
TSH. Timepoint: before and after the end of intervention. Method of measurement: using ELISA Kit.;T4. Timepoint: before and after the end of intervention. Method of measurement: using ELISA Kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHanieh Berahman

Islamic Azad University

hanie_berahman@yahoo.com+98 13 3342 2153

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026